Access Delivery Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Access delivery research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Access Delivery Research Today - Breaking & Trending Today

Large Remdesivir Study Finds No COVID-19 Survival Benefit


Large Remdesivir Study Finds No COVID-19 Survival Benefit
July 16, 2021 A lack of consensus regarding the antiviral drug remdesivir to treat people with COVID-19 continues, leaving doctors without clear direction on one of the few treatments for the illness the FDA has granted emergency use authorization.
The latest research comes from Michael Ohl, MD, and colleagues who studied a large group of Veterans Administration patients hospitalized with COVID-19. Compared with a matched group of veterans who did not receive the antiviral, remdesivir did not significantly improve survival rates
The percentages were close: 12.2% of patients in the remdesivir group died within 30 days compared to 10.6% of those in the control group. ....

United States , Michael Ohl , Iowa City Veterans Affairs Health Care System , Access Delivery Research , Veterans Administration , Infectious Diseases Society Of America , Infectious Diseases Society , Delivery Research , ஒன்றுபட்டது மாநிலங்களில் , ஐயுவா நகரம் வீரர்கள் வாழ்க்கைத்தொழில்கள் ஆரோக்கியம் பராமரிப்பு அமைப்பு , நுழைவு டெலிவரி ஆராய்ச்சி , தொற்று நோய்கள் சமூகம் ஆஃப் அமெரிக்கா , தொற்று நோய்கள் சமூகம் , டெலிவரி ஆராய்ச்சி ,